Felson DT, Anderson JJ, Naimark A, et al: The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham study. .J Rheumatol 16::1241. ,1989. .
Doherty M, Dieppe P, Watt I: Pyrophosphate arthropathy: a prospective study. .Br J Rheumatol 32::189. ,1993. .
Sanmarti R, Panella D, Brancos MA, et al: Prevalence of articular chondrocalcinosis in elderly subjects in a rural area of Catalonia. .Ann Rheum Dis 52::418. ,1993. .
McCarty DJ: Calcium pyrophosphate dihydrate crystal deposition disease: nomenclature and diagnostic criteria. .Ann Intern Med 87::241. ,1977. .
Martinez Taboada VM, Blanco Alonso R, Alonso Bartolome B, et al: Artropatías microcristalinas: II. Artritis por pirofosfatos. .Medicine 8::1773. ,2001. .
Uri DS, Dalinka MK: Imaging of arthropathies: crystal disease. .Radiol Clin North Am 34::359. ,1996. .
Fam AG, Topp JR, Stein HB, et al: Clinical and roentgenographic aspects of pseudogout: a study of 50 cases and review. .Can Med Assoc J 124::545. ,1981. .
de Lange EE, Keats TE: Localized chondrocalcinosis in traumatized joints. .Skeletal Radiol 14::249. ,1985. .
Hanft JR, Kashuk KB, Schabler JA: Pseudogout of the ankle: a case study and arthroscopic-assisted treatment. .J Foot Surg 30::173. ,1991. .
Kobayashi S, Sugenoya A, Takahashi S, et al: Two cases of acute pseudogout attack following parathyroidectomy. .Endocrinol Jpn 38::309. ,1991. .
Weinfeld SB, Schon LC: Hallux metatarsophalangeal arthritis. .Clin Orthop Relat Res 349::9. ,1998. .
Luisiri P, Blair J, Ellman MH: Calcium pyrophosphate dihidrate deposition disease presenting as tumoral calcinosis (periarticular pseudogout). .J Rheumatol 23::1647. ,1996. .
Jarret MP, Grayzel AI: Simultaneous gout, pseudogout, and septic arthritis. .Arthritis Rheum 23::128. ,1980. .
Smith RJ, Phelps P: Septic arthritis, gout, pseudogout and osteoarthritis in the knee of a patient with multiple myeloma. .Rheumatology 15::89. ,1972. .
Feller SR, Block P: Sepsis and calcium pyrophosphate deposition disease in the same joint: a case report. .JAPMA 75::158. ,1985. .
Gennant HK, Heck LL, Lanzi LH, et al: Primary hyperparathyroidism: a comprehensive study of clinical, biochemical and radiographic manifestations. .Radiology 109::513. ,1973. .
Hamilton EB, Bomford AB, Laws JW, et al: The natural history of arthritis in idiopathic haemochromatosis: progression of the clinical and radiological features over ten years. .Q J Med 199::321. ,1981. .
Jones AC, Chuck AJ, Ane EA, et al: Diseases associated with calcium pyrophosphate deposition disease. .Semin Arthritis Rheum 22::188. ,1992. .
Sanmarti R, Serrarols M, Galinsoga A, et al: Enfermedades asociadas a la condrocalcinosis articular: analisis de una serie de 95 casos. .Med Clin 101::249. ,1993. .
Hollingworth P, Williams PL, Scott JT: Frequency of chondrocalcinosis of the knees in asymptomatic hyperuricemia and rheumatoid arthritis: a controlled study. .Ann Rheum Dis 41::344. ,1982. .
Falsetti P, Frediani B, Acciai C, et al: Ultrasonographic study of Achilles tendon and plantar fascia in chondrocalcinosis. .J Rheumatol 31::2242. ,2004. .
Calcium pyrophosphate dihydrate crystal deposition disease has various clinical features, and pseudogout is one of the six clinical forms. Chondrocalcinosis is the term used to describe the radiographic appearance of the disease. A review of the literature revealed that the appearance of this type of arthropathy in the foot is infrequent. We offer a review of the disease and report an atypical bilateral case of pseudogout in a patient 56 years of age without a history who presented with symptoms of arthritis localized in the first metatarsophalangeal joint associated with hallux valgus and was treated surgically. Radiographic evaluation of the feet did not reveal signs of chondrocalcinosis. The patient had no metabolic abnormalities, except for high uric acid values. Chemical analysis of the surgical samples demonstrated the presence of calcium pyrophosphate dihydrate crystals, confirming the diagnosis. We believe that arthropathy by deposition of calcium pyrophosphate dihydrate in the foot, although rare, must be considered in the podiatric physician’s differential diagnosis when a patient presents with articular pain in the foot associated or not with deformities. (J Am Podiatr Med Assoc 100(2): 138–142, 2010)